Taiwan FDA registration d7ce04b32b6240f53aa6bf638944c44a

Rinli Hyaluronic Acid Multi-Action Maintenance Solution

TW: 沖立淨玻尿酸多效保養液

Taiwan·Risk Class 2·NANG KUANG PHARMACEUTICAL CO., LTD.·Registered Mar 09, 2021 – Oct 31, 2029Active

Registration details

Analysis ID: d7ce04b32b6240f53aa6bf638944c44a

Company information

Manufacturer: NANG KUANG PHARMACEUTICAL CO., LTD.
Manufacturer Country: Taiwan, Province of China
Authorized Representative: NANG KUANG PHARMACEUTICAL CO., LTD.

Product details

Intended Use: For details, it is Chinese approved copy of the imitation order
Product Type (Level 1): M Ophthalmology
Product Type (Level 2): M.5928 Products for the preservation of soft contact lenses;; M.5918 Rigid Breathable Contact Lens Preservation Products
Import Information: Domestic

Dates and status

Registration Date: Mar 09, 2021
Expiry Date: Oct 31, 2029

About this record

Access comprehensive regulatory information for Rinli Hyaluronic Acid Multi-Action Maintenance Solution in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number d7ce04b32b6240f53aa6bf638944c44a and manufactured by NANG KUANG PHARMACEUTICAL CO., LTD.. The authorized representative in Taiwan is NANG KUANG PHARMACEUTICAL CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.